The constraints of the a blocking patent are conceptually another thing - perhaps a different thing physically. The answer to that is something the court may opine.
No perhaps at all in this. Here is the Copax lable description:
That comes out to 4.49:1.48:3.56:1, which is not 6:2:5:1 in my book.
How well this argument works in court is one issue, but it is obviously possible for mC to have the same molar fraction as Copaxone but not the described 6:2:5:1.
[BTW, the 6:2:5:1 relates to copolymer-1 in general, not the improved version. So this might not be a very strong argument if the process of excluding the big chains somewhat shifts these numbers]
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.